160 related articles for article (PubMed ID: 16295416)
1. Pathological spectrum of cytomegalovirus infection of renal allograft recipients-an autopsy study from north India.
Joshi K; Nada R; Radotra BD; Jha V; Sakhuja V
Indian J Pathol Microbiol; 2004 Jul; 47(3):327-32. PubMed ID: 16295416
[TBL] [Abstract][Full Text] [Related]
2. Polyomavirus nephropathy and Cytomegalovirus nephritis in renal allograft recipients.
Agrawal V; Gupta RK; Jain M; Prasad N; Sharma RK
Indian J Pathol Microbiol; 2010; 53(4):672-5. PubMed ID: 21045390
[TBL] [Abstract][Full Text] [Related]
3. Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients.
Park SB; Kwak JH; Lee KT; Hwang EA; Han SY; Kim HT; Cho WH; Choi MS; Kim HC
Transplant Proc; 2006 Sep; 38(7):2059-61. PubMed ID: 16979999
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of cytomegalovirus-induced renal pathology in renal allograft recipients.
Rane S; Nada R; Minz M; Sakhuja V; Joshi K
Transplant Proc; 2012 Apr; 44(3):713-6. PubMed ID: 22483475
[TBL] [Abstract][Full Text] [Related]
5. Renal allograft dysfunction associated with cytomegalovirus infection.
Shaver MJ; Bonsib SM; Abul-Ezz S; Barri YM
Am J Kidney Dis; 1999 Nov; 34(5):942-6. PubMed ID: 10561154
[TBL] [Abstract][Full Text] [Related]
6. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection.
Helanterä I; Loginov R; Koskinen P; Lautenschlager I
Transpl Int; 2008 Oct; 21(10):980-4. PubMed ID: 18564986
[TBL] [Abstract][Full Text] [Related]
8. Severe tubulo-interstitial disease in a renal allograft due to cytomegalovirus infection.
Cameron J; Rigby RJ; van Deth AG; Petrie JJ
Clin Nephrol; 1982 Dec; 18(6):321-5. PubMed ID: 6295675
[TBL] [Abstract][Full Text] [Related]
9. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients.
Haririan A; Morawski K; West MS; El-Amm JM; Doshi MD; Cincotta E; Alangaden GJ; Chandrasekar P; Gruber SA
Clin Transplant; 2007; 21(4):466-71. PubMed ID: 17645705
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients.
Leroy F; Sechet A; Abou Ayache R; Thierry A; Belmouaz S; Desport E; Bauwens M; Bridoux F; Touchard G
Transplant Proc; 2006 Sep; 38(7):2324-6. PubMed ID: 16980080
[TBL] [Abstract][Full Text] [Related]
12. Histologic evidence of cytomegalovirus in the duodenal and gastric mucosa of patients with renal allograft.
Franzin G; Novelli P; Fratton A
Endoscopy; 1980 May; 12(3):117-20. PubMed ID: 6247148
[TBL] [Abstract][Full Text] [Related]
13. Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection.
Helanterä I; Teppo AM; Koskinen P; Törnroth T; Grönhagen-Riska C; Lautenschlager I
Transpl Immunol; 2006 Jan; 15(3):217-21. PubMed ID: 16431289
[TBL] [Abstract][Full Text] [Related]
14. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
15. Renal changes in cytomegalovirus infection.
Castro LA; Gokel JM; Thoenes G; Frösner G; Land W; Hillebrand G; Gurland HJ
Proc Eur Dial Transplant Assoc; 1983; 19():500-4. PubMed ID: 6308601
[TBL] [Abstract][Full Text] [Related]
16. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus and kidney.
Battegay EJ; Mihatsch MJ; Mazzucchelli L; Zollinger HU; Gudat F; Thiel G; Heitz PU
Clin Nephrol; 1988 Nov; 30(5):239-47. PubMed ID: 2850879
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.
John GT; Manivannan J; Chandy S; Peter S; Fleming DH; Chandy SJ; Balakrishnan N; Krishnamurthy K; Kirubakaran MG; Jacob CK
Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus-associated severe fatal necrotizing pancreatitis in a patient with interstitial pneumonitis treated with steroids. An autopsy case.
Terada T
JOP; 2011 Mar; 12(2):158-61. PubMed ID: 21386644
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in children: frequency, anatomopathologic characteristics and underlying risk factors in 1618 autopsies.
Peña-Alonso R; Navarrete-Navarro S; Ramon-Garcia G; Hernandez-Mote R; Rodriguez-Jurado R
Arch Med Res; 1996; 27(1):25-30. PubMed ID: 8867363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
